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Abstract
Burkholderia multivorans is a member of the Burkholderia cepacia complex (Bcc), notorious
for its pathogenicity in persons with cystic fibrosis. Epidemiological surveillance suggests
that patients predominantly acquire B. multivorans from environmental sources, with rare
cases of patient-to-patient transmission. Here we report on the genomic analysis of thirteen
isolates from an endemic B. multivorans strain infecting four cystic fibrosis patients treated
in different pediatric cystic fibrosis centers in Belgium, with no evidence of cross-infection.
All isolates share an identical sequence type (ST-742) but whole genome analysis shows
that they exhibit peculiar patterns of genomic diversity between patients. By combining short
and long reads sequencing technologies, we highlight key differences in terms of small
nucleotide polymorphisms indicative of low rates of adaptive evolution within patient, and
well-defined, hundred kbps-long segments of high enrichment in mutations between
patients. In addition, we observed large structural genomic variations amongst the isolates
which revealed different plasmid contents, active roles for transposase IS3 and IS5 in the
deactivation of genes, and mobile prophage elements. Our study shows limited within-
patient B. multivorans evolution and high between-patient strain diversity, indicating that an
environmental microdiverse reservoir must be present for this endemic strain, in which
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active diversification is taking place. Furthermore, our analysis also reveals a set of 30 paral-
lel adaptations across multiple patients, indicating that the specific genomic background of a
given strain may dictate the route of adaptation within the cystic fibrosis lung.
Author summary
In many countries, Burkholderia multivorans is the most prevalent species within the Bur-
kholderia cepacia complex (Bcc) found infecting the lungs of patients with cystic fibrosis
(CF). Its positive identification is of immediate concern to the health of the patient as it is
notoriously hard to eradicate using antibiotics and can cause necrosis of the lung tissues
(cepacia syndrome). Infection control measures reduced the prevalence of B. cenocepacia in
CF wards, but patients continue to acquire infections by B. multivorans from environmental
sources. In most reported cases, the infecting strains are unique except in rare cases in
which cross-infection is observed between patients. We report here an endemic strain of B.
multivorans with sequence type ST-742 that has been infecting multiple patients, without
evidence for cross-infection. We investigated the epidemiology and genomics of this ST-742
strain and show that it is microdiverse, as isolates between-patients exhibit numerous geno-
mic differences, at scales that have not been observed previously when looking at evolution-
ary trajectories within-patients. Additionally, we found that the specific genomic
background of a given strain may dictate the strategy of adaptation within the CF lung.
Introduction
Burkholderia cepacia complex (Bcc) bacteria are relatively rare but notorious opportunistic
pathogens in cystic fibrosis (CF) patients. They are associated with higher rates of morbidity
and mortality, as well as lower post-lung transplant survival [1–4]. Bcc infections in CF are
characterized by highly variable clinical outcomes, but commonly result in a progressive
decline of lung function. In extreme cases, Bcc infection can result in "cepacia syndrome", a
necrotizing pneumonia and septicemia that engages a lethal prognosis for the patient [5]. Bcc
infections are difficult to eradicate because the infecting strains have an innate resistance to
multiple antibiotics [3,4,6].
Infection control measures and patient segregation were globally implemented in the 1990s
to reduce patient-to-patient transmission and thereby the prevalence of Burkholderia cenoce-
pacia [7–10]. Subsequently, Burkholderia multivorans emerged as the most prevalent Bcc rep-
resentative in many countries [1,2,4,11–13]. B. multivorans is considered less virulent than B.
cenocepacia [6,8] and infections are often characterized as chronic with episodes of exacerba-
tions [3,4]. Nevertheless, several cases of “cepacia syndrome” and B. multivorans epidemic out-
breaks have been reported [14–17].
The ability to differentiate Bcc strains has been key in understanding their epidemiology
and improving infection control guidelines for the CF community. Multilocus sequence typing
(MLST) is a well-established molecular technique to study the epidemiology and population
structure of Bcc organisms [18–20]. The Bcc MLST scheme is based on the allelic variations of
seven housekeeping genes (atpD, gltB, gyrB, recA, lepA, phaC and trpB) and each strain is
defined by its unique allelic profile and sequence type (ST) [18,21]. While several B. multivor-
ans STs were shown to be globally distributed [22,23], only a limited number of genetically dis-
tinct B. multivorans outbreak strains have been described [22]. The small number of B.
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multivorans outbreaks and the fact that B. multivorans isolates from CF patients mostly repre-
sent unique strains strongly suggest that person-to-person transmissions are limited and that
B. multivorans strains are usually acquired from environmental sources [10,12,22,24,25].
B. multivorans has been the most prevalent Bcc species in Belgian CF patients for more
than three decades [1,26,27]. B. multivorans isolates from Belgian CF patients typically repre-
sent unique strains, but rather unexpectedly, several B. multivorans isolates with the same
sequence type (ST-742) were found in multiple Belgian CF patients treated in different CF cen-
ters [26,28]. A study was performed to investigate the epidemiology and risk factors that play a
role in the spread of these clones, but no evidence to support cross-infection was detected [26],
suggesting these patients acquired this B. multivorans strain from the natural environment.
The aim of the current study was to investigate the genomic epidemiology and evolution of B.
multivorans ST-742 that were isolated from respiratory samples of four Belgian CF patients over
a period of at least ten years. We combined sequencing technologies to enable an optimal resolu-
tion in the de novo reconstruction of the genomes and elucidation of structural variations
[29,30], with clinical and antibiotic resistance data to discriminate between ST-742 isolates. We
show that ST-742 isolates of different patients have distinct genomic profiles and propose that
each patient has been colonized independently from a natural reservoir of ST-742 where recom-
bination events diversify the population of this microdiverse endemic B. multivorans strain.
Results
Isolates from four different patients share the same sequence type
Between 2009 and 2019, thirteen B. multivorans isolates with ST-742 were obtained from respi-
ratory samples of four unrelated patients attending three different pediatric CF centers in Bel-
gium (Fig 1, Table 1, Table A in S1 Tables) [26].
Variability of antibiotic resistance profiles in the ST-742 isolates
We tested the susceptibility of our isolates to 20 different antibiotics and interpreted as resis-
tant, low level of resistance, or susceptible based on EUCAST interpretation of the Minimum
Inhibitory Concentrations (MIC) value when available, or the species independent Pharmaco-
kinetics/Pharmacodynamics (PK/PD) interpretation otherwise (Fig 2). The complete table
with the MIC values is given in Table B in S1 Tables.
Isolates of the first positive cultures (i.e., P1Bm2009 and P3Bm2015) were susceptible to
multiple antibiotics (Fig 2). Interestingly, P2Bm2011b, and P4Bm2019 also display similar pro-
files despite not being the first B. multivorans isolate for the respective patients. For patient 1,
pairs of isolates from the same sample with distinct colony morphologies (P1Bm2011a-b,
P1Bm2012a-b) showed highly similar or identical profiles; the last isolate (P1Bm2015) was
resistant to all antibiotics tested, except trimethoprim/sulfamethoxazole. For patient 2, the two
isolates from the same sample with distinct colony morphologies (P2Bm2011a-b) showed dif-
ferent profiles: one isolate (P2Bm2011b) had a resistance profile similar to that of other initial
isolates (i.e. P1Bm2009 and P3Bm2015), while the other isolate (P2Bm2011a) had a resistance
profile that resembled that of later isolates such as P1Bm2012b. The resistance profile of the
isolate P2Bm2018 was most similar to that of P2Bm2011a and P1Bm2012b (Fig 2).
The replicons are collinear and broadly share nucleotide sequence identity
across isolates
The hybrid sequencing data, combining Nanopore and Illumina sequencing, enabled highly
contiguous de novo reconstructions of the genomes for all thirteen isolates. The genomes
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ranged between 6.5 and 6.7 Mb in size with a G+C content of approximately 67%. The func-
tional annotation revealed 5,837 to 6,045 coding DNA sequences (CDS) per genome (Table 1).
The annotation of antibiotic resistance genes revealed a single class A beta-lactamase encoding
gene that was present in all isolates and was a homolog to penA, previously identified in B.
cepacia ATCC 25416 (NG_048030.1). Each of the replicons contained multiple genomic
islands that included prophage elements and secondary metabolites (Table C in S1 Tables). No
clustered regularly interspaced short palindromic repeats (CRISPRs) were found.
The assembly graphs (S1 Fig) confirmed the typical highly conserved genome structure of
B. multivorans with three large replicons [6,23] (from here on referred to as C1, C2 and C3).
The genomic sequences of each of the three chromosomes across all isolates were collinear (S2
Fig) and broadly shared nucleotide sequence identity (>99.8%).
The B. multivorans population structure reveals a unique, clonal ST-742
cluster
There are no other reports of ST-742 isolates in the Bcc PubMLST database [31]. Furthermore,
MLST analysis of all publicly available B. multivorans genomes (Table D in S1 Tables) did not
Fig 1. Timeline of B. multivorans ST-742 isolations from sputum samples in Patients 1 to 4. Each dot represents an
isolate (exact isolation dates in Table 1). The 2011 and 2012 isolates of patient 1 and 2012 isolates of patient 2 each
originated from the same sputum sample and were studied in parallel as they displayed distinct colony morphologies.
The line connecting the isolates indicates the infection timeline, with the infections of patients 2 and 4 still currently
ongoing.
https://doi.org/10.1371/journal.ppat.1009418.g001
Table 1. List of isolates included in our study. Isolates marked with an asterisk were obtained from the same sputum sample but displayed distinct colony morphologies.
Culture date Size (bp) CDS NCBI Accession
Patient 1 (˚1999)
P1Bm2009 29/01/2009 6,569,085 5,917 CP048460-63
P1Bm2011a 31/03/2011� 6,498,339 5,830 CP048557-59
P1Bm2011b 31/03/2011� 6,531,926 5,829 CP048454-56
P1Bm2012a 16/02/2012� 6,545,859 5,828 JAAEEF000000000
P1Bm2012b 16/02/2012� 6,495,911 5,828 CP048451-53
P1Bm2013 25/07/2013 6,496,014 5,830 JAAEEE000000000
P1Bm2014 21/01/2014 6,497,010 5,831 CP048448-50
P1Bm2015 12/06/2015 6,499,180 5,833 CP048445-47
Patient 2 (˚2004)
P2Bm2011a 11/07/2011� 6,705,051 5,982 CP048441-44
P2Bm2011b 11/07/2011� 6,707,647 5,983 JAAEED000000000
P2Bm2018 20/08/2018 6,661,721 5,988 JACKVR000000000
Patient 3 (˚2006)
P3Bm2015 09/11/2015 6,725,592 6,045 JAAEEC000000000
Patient 4 (˚1992)
P4Bm2019 23/12/2019 6,538,969 5,799 JACKVS000000000
https://doi.org/10.1371/journal.ppat.1009418.t001
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reveal other ST-742 isolates either. To examine the position of ST-742 isolates in the general
population structure of B. multivorans a core-genome based phylogenomic analysis was per-
formed of the genomes of our thirteen ST-742 isolates together with 97 publicly available B.
multivorans genomes (Table D in S1 Tables). The core genome consisted of 995 genes that
were used to build a multiple sequence alignment and construct a core-genome phylogeny
Fig 2. Antibiotic resistance profiles of the thirteen isolates. MIC values (Table B in S1 Tables) were interpreted using
the EUCAST or PK/PD when available, and the results are summarized visually: Red = resistant, orange = low level of
resistance, and green = sensitive.
https://doi.org/10.1371/journal.ppat.1009418.g002
Fig 3. Population structure of Burkholderia multivorans. We established the population structure via the isolation of core genes across all publicly
available B. multivorans genomes in order to position our cluster of isolates in the population. We collapsed the subtree (highlighted in red) consisting of
our thirteen ST-742 isolates as they showed to be clonal within the population. B. cenocepacia J2315 was used as outgroup. The strains highlighted in
green are from the study by Silva et al. (2016) and Caballero et al. (2018), D2095 with D2214 and Bmul_CF170.1a respectively.
https://doi.org/10.1371/journal.ppat.1009418.g003
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(Fig 3). This analysis demonstrated that ST-742 isolates represent a unique line of descent
within B. multivorans with FDAARGOS_719, a clinical isolate from the US [32], as nearest
neighbor.
To further investigate the evolutionary relationships within the ST-742 cluster, a SNP analy-
sis was performed to detect small insertions or deletions (indels) and single nucleotide poly-
morphisms (SNPs) in the ST-742 genomes and the FDAARGOS_719 genome. The resulting
core SNP alignment was used for a second, more detailed phylogenetic analysis (Fig 4). While
all patient 1 isolates clustered closely together, this was not the case for the isolates from patient
2. Indeed, the core SNP analysis revealed that the two initial patient 2 isolates (P2Bm2011a-b)
were more similar to each other and to the single patient 4 isolate (P4Bm2019), than to the
later isolate of patient 2 (P2Bm2018) (Fig 4).
Distinct plasmid content and large structural variations between patients
Plasmids could be detected in at least one isolate of each of the four patients but appears to be
lost during chronic infection (patient 1 and 2). Pairwise comparisons of these four plasmid
sequences using BLASTn revealed that the plasmid of patient 1 isolate P1Bm2009 had only 4%
coverage with high identity (97%) to the group of plasmids found in patient 2, 3, and 4
(P2Bm2011a-b, P3Bm2015, and P4Bm2019). When compared against the NCBI nr/nt data-
base [33], we found a best BLASTn hit (83% identity over 20% sequence coverage) to the
pINT23 plasmid of Burkholderia pseudomultivorans SUB-INT23-BP2 (CP013379.1). On the
other hand, the group of plasmids from the first isolates of patients 2 to 4 shared a pairwise
sequence identity and coverage of over 99% and had a best database hit (99% identity and 66%
Fig 4. Core-SNP phylogeny of the ST-742 isolates. We used the information contained in the 61,845 core SNPs
found between our cluster of ST-742 isolates and the strain FDAARGOS_719 to further zoom in on the evolutionary
relations between the ST-742 isolates.
https://doi.org/10.1371/journal.ppat.1009418.g004
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sequence coverage) to the pTGL1 plasmid of Burkholderia multivorans ATCC 17616
(AP009388.1). The functional content of the plasmids found in P1Bm2009 and P2Bm2011a
(taken as representative of the group of plasmids found in P2Bm2011a-b, P3Bm2015, and
P4Bm2019) is described in Tables E and F of S1 Tables. The plasmids differ extensively in size
(72 kbp for P1Bm2009 and 162 kbp for P2Bm2011a) and in functional content. Indeed, over
24% of the large plasmid genes (P2Bm2011a) are related to DNA maintenance and repair com-
pared to 9% in the small plasmid (P1Bm2009) (Table F of S1 Tables). Both plasmids contain
proteins linked to Type IV secretion systems, with the smaller plasmid (P1Bm2009) specifically
carrying a VirB4 component. Importantly, we did not identify any antibiotics resistance asso-
ciated genes on those plasmids.
The long-read sequencing data were further used to survey larger structural variations
between isolates (Table 2, Tables G and H of S1 Tables). This analysis revealed an active role
for transposons from families IS3 and IS5 in the deactivation of genes (Table 2), particularly in
the isolates from patient 2. Additionally, three complete prophages were present in all isolates
except those of patient 2, in which they appear to be actively mobile. Indeed, the prophage
located on C3 was absent from all isolates of patient 2, but the prophage on C2 was absent in
P2Bm2011b, while the prophage on C1 was absent in P2Bm2011a and P2Bm2018.
Table 2. Large structural variations in the isolates of Patient 2–4. By setting the isolate P1Bm2009 as a reference, we mapped the long Nanopore reads of the isolates
from patients 2 to 4 to identify large structural variations that escape SNPs analysis. We omitted from this list indels found in intergenic regions (11) and hypothetical pro-
teins (8). The full list of structural variations can be found in Tables G and H in S1 Tables.
Strains Chr Position Function
P2Bm2011b 1 17536 Insertion of IS3 into type IV secretion system tip protein VgrG
P2Bm2011b, P2Bm2018 1 59006 Insertion of IS5 into intergenic promoter of type II secretion system secretin GspD
P2Bm2018 1 482440 Deletion in long-chain fatty acid—CoA ligase
P4Bm2019 1 762540 Deletion EamA family transporter, hypothetical prot, RES family NAD+ phosphorylase
P4Bm2019 1 825939 Deletion glutamine—fructose-6-phosphate transaminase (isomerizing)
P2Bm2011b, P2Bm2018 1 860357 Large deletion including regulator proteins
P2Bm2011b, P2Bm2018 1 1084705 Deletion IS3 family transposase
P2Bm2011b 1 1126373 Insertion of IS3 into GlxA family transcriptional regulator
P2Bm2011b, P2Bm2018, P4Bm2019 1 1250973 Deletion IS256 family transposase
P2Bm2011b 1 1383320 Insertion of IS5 into ornithine acetyltransferase
P2Bm2011a, P2Bm2018 1 2112493 Prophage deletion
P2Bm2011a, P2Bm2018 1 2882469 Insertion of IS5 into PTS sugar transporter/HPr kinase/phosphorylase
P2Bm2011a,b, P2Bm2018 2 199631 Deletion in polyketide cyclase
P2Bm2011b, P2Bm2018 2 234973 Insertion of IS5 into peroxidase-related enzyme
P2Bm2011b 2 297796 Insertion of IS5 into transposase
all 2 386097 Deletion IS3 family transposase
P2Bm2011b 2 851128 Insertion of IS5 into type IV secretion system baseplate subunit TssF
P2Bm2011b 2 865794 Insertion of IS3 into DUF3304 domain-containing protein
P2Bm2018 2 906456 Insertion of IS5 into DEAD/DEAH box helicase
P2Bm2011b 2 921221 Insertion of IS5 into multidrug transporter subunit MdtN
P2Bm2011b 2 1052623 Insertion of IS5 into twin-arginine translocation pathway signal
P2Bm2011b, P2Bm2018 2 1770117 Insertion of IS5 into Tat pathway signal protein
P2Bm2011b 2 1892870 Prophage deletion
P2Bm2011b 2 2294168 Insertion of IS5 into aldo/keto reductase
P2Bm2011a,b, P2Bm2018 3 128274 Prophage deletion
P2Bm2011a,b 3 599926 Insertion of IS5 into PLP-dependent aminotransferase family protein
https://doi.org/10.1371/journal.ppat.1009418.t002
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ST-742 isolates have regions with unusually high SNP densities in C1 and
C2
To assess in which regions of the chromosomes SNPs occurred, all identical SNPs found on
the different genomes of isolates from patient 1 were collapsed into a single collection of SNPs
(85 in total). The same analysis was performed on the isolates P2bm2011a and P2Bm2011b
from patient 2 (4,694 in total). However, the later isolate of patient 2 (P2Bm2018) was kept
separated as it displayed a large number of unique variants (1,990 SNPs when compared to
P2Bm2011a-b, S3 Fig).
Figs 5, 6 and 7 visually summarize the SNP densities for each chromosome and sets of iso-
lates. The full list of SNPs is provided in Table I in S1 Tables. S3 Fig shows the number of
shared SNPs among the isolates.
In general, SNPs were randomly distributed across the chromosomes, with 53, 20 and 12
SNPs on C1, C2 and C3 of isolates from patient 1, respectively. However, an enrichment of
SNPs was detected in three regions for the isolates from the other patients: a first centered
around position 900 kbp for C1 (Fig 5), and a second and third in C2 around 170 kbp and 310
kbp, respectively (Fig 6). No such pattern was observed in the smaller C3 (Fig 7). On C1, this
region of P2Bm2011a-b, P2Bm2018, P3Bm2015 and P4Bm2019 all ended at the exact same
position (991,509) but started at different positions (702,401–794,204) (Table J in S1 Tables).
On C2, the enrichment of SNPs was observed in all isolates except in isolate P3Bm2015 (Fig 6).
These regions all start at the same position (150,841 and 318,125) but ended at different posi-
tions (193,566–204,452 and 331,399–331,929). The analysis of the functional content found in
these regions did not reveal specific enrichments for certain COG categories when compared
to the whole genomic background of the strain (Table M in S1 Tables).
Genome evolution of patient 1 isolates over the course of the infection and
parallel evolution in different patients
To reveal within-patient genomic variations at the level of SNPs and larger structural variations,
the genomes of all sequential isolates of patient 1 were compared using isolate P1Bm2009 as a
reference. When collapsing all SNPs as described above, a total of 85 unique SNPs were detected
on the three chromosomes. Many of these mutations were fixed over time once they appeared
(Fig 8, Table I in S1 Tables). Some genes had mutations at multiple independent positions (Fig 8,
Table 3). Both pairs of isolates P1Bm2011a-b and P1Bm2012a-b, which originated from the
same sputum samples but displayed a different colony morphology, also showed a distinct SNP
profile. This suggests an evolution of different population lineages within this patient. These 85
SNPs occurred over six years, yielding an average mutation rate of 15 SNPs/year (S4 Fig).
Additionally, we searched for evidence of parallel evolution of loci across multiple patients.
In total, 30 CDS (and ten non-coding regions) were detected with mutations in at least three
patients, and only two loci (129 and 6144) had mutations in all patients (Table I in S1 Tables
and Table 4).
Larger structural variations that were not detected using the SNP analysis included the loss
of a plasmid that was only detected in the first isolate P1Bm2009 (see above), as well as several
deletions and insertions, some of which could again be linked to transposase activity (Table 5,
Table H in S1 Tables).
Discussion
B. multivorans has been the most prevalent Bcc species in Belgian CF patients for more than
three decades [1,26,27] and patients generally carry distinct sequence types, suggesting the
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presence of many different B. multivorans STs in environmental reservoirs [22]. In contrast,
between 2009 and 2019, ST-742 isolates were found in respiratory samples of four patients
attending three different CF centers [26,28]. To investigate the epidemiology and evolution of
these ST-742 isolates, we examined their genome sequences and their susceptibility to antimi-
crobial agents commonly used in CF therapy.
The high level of sequence identity, the collinearity of the replicons (S2 Fig), and the com-
parison with other publicly available B. multivorans genomes (Fig 4) demonstrated that all ST-
742 isolates belonged to a single genomic lineage and that the shared ST was not simply a result
of homoplasy [34,35]. This also corroborated an earlier study that showed that the ST pre-
dicted both phylogeny and gene content of B. multivorans isolates, supporting the use of
MLST for epidemiological surveillance of Bcc bacteria [23].
The lack of evidence to support cross-infection [26] suggested that all patients acquired B.
multivorans ST-742 from an environmental reservoir and that this strain is endemic in Bel-
gium. A recent genomic study of B. multivorans reported that the same genomic lineages were
isolated from CF and environmental samples and on different continents many years apart,
Fig 5. Features of chromosome 1 and SNP densities comparisons. In concentric circles, from the center and outward are depicted: 1) the GC skew, 2) the
GC content, 3) the genomic islands detected by the software IslandViewer 4 (in purple), the prophages detected with Phaster (green) and the secondary
metabolites identified by antiSMASH (in blue), 4) a total of five SNP densities, we separated the isolates from 2011 and the isolate from 2018 in patient 2 as
we regard them as two separate acquisition events, 5) and 6) the annotated features found on the negative and positive strand respectively.
https://doi.org/10.1371/journal.ppat.1009418.g005
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demonstrating the evolutionary persistence and ubiquity of these strains in different niches
and on different continents [23]. Intriguingly, although several studies point towards the
acquisition of B. multivorans from non-human sources such as the natural environment, its
preferred natural habitat remains elusive [4,36].
Different elements suggest that this environmental reservoir holds a microdiverse B. multi-
vorans ST-742 population [37] that is susceptible to several antimicrobial agents and from
which different genetic variants colonized different patients. First, there is a considerable SNP
diversity between genomes of isolates of different patients compared to the more limited diver-
sity observed among the genomes of patient 1 isolates (Fig 4). Second, we observed different
start positions of the high-density SNP regions in isolates from different patients (Figs 5, 6 and
7, Table 2). Third, we observed an apparent mobility of prophage elements which are differen-
tially present in some isolates. Lastly, there was a shared plasmid present in the isolates of
patient 2, 3 and 4 and a unique plasmid in the first isolate of patient 1 (Table A in S1 Tables).
Indeed, this microdiverse B. multivorans ST-742 population appears to comprise different
plasmids which can be dispensed once in a human host.
Fig 6. Features of chromosome 2 and SNP densities comparisons. In concentric circles, from the center and outward are depicted: 1) the GC skew, 2) the
GC content, 3) the genomic islands detected by the software IslandViewer 4 (in purple), the prophages detected with Phaster (green) and the secondary
metabolites identified by antiSMASH (in blue), 4) a total of five SNP densities, we separated the isolates from 2011 and the isolate from 2018 in patient 2 as
we regard them as two separate acquisition events, 5) and 6) the annotated features found on the negative and positive strand respectively.
https://doi.org/10.1371/journal.ppat.1009418.g006
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De Boeck et al. [1] reported on the re-appearance of Bcc strains up to ten years after first
colonization and hypothesized that reacquisition from the environment occurred. In patient 2,
we hypothesize that isolate P2Bm2018 is derived from a re-infection from the same environ-
mental reservoir and is not an immediate evolutionary descendant of the previously reported
isolates of this patient (P2Bm2011a-b). This hypothesis is supported by the position of isolate
P2Bm2018 in the core SNP tree (Fig 4), its different SNP profile (Figs 5, 6 and 7) with 1,990
unique SNPs when compared to P2Bm2011a-b, the presence of different regions with high
SNP content in C1 and C2 (Table J in S1 Tables) and a differing pattern of prophage elements
between early isolates (P2Bm2011a-b) and the late isolate (P2Bm2018). However, no plasmid
was detected in P2Bm2018 and the antibiotic resistance profile of P2Bm2018 resembled that of
P2Bm2011a (Fig 2), potentially indicating that the lineage of that isolate was already estab-
lished in the lungs of the patient before 2018.
Comparative genomic analyses of Bcc isolates sampled from single patients in the course of
chronic infections have shown that diversifying lineages can co-exist in the CF lungs for many
years, with limited rates of evolution (as proxied by single nucleotide polymorphisms), i.e.
around 2.1 to 2.4 SNPs/year [38–43]. This evolution within the lungs of CF patients can result
Fig 7. Feature of chromosome 3 and SNP densities comparisons. In concentric circles, from the center and outward are depicted: 1) the GC skew, 2) the
GC content, 3) the genomic islands detected by the software IslandViewer 4 (in purple), the prophages detected with Phaster (green) and the secondary
metabolites identified by antiSMASH (in blue), 4) a total of five SNP densities, we separated the isolates from 2011 and the isolate from 2018 in patient 2 as
we regard them as two separate acquisition events, 5) and 6) the annotated features found on the negative and positive strand respectively.
https://doi.org/10.1371/journal.ppat.1009418.g007
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in the loss of plasmids, increased antimicrobial resistance and a subset of genes that undergo
positive selection [38,40,42–44].
In the present study, the presence of co-existing clades was supported in samples of patients
1 and 2, in which the same sample yielded isolates with distinct colony morphologies that
showed distinct antibiotic resistance profiles (Fig 2, P2Bm2011a-b) and SNP profiles (Fig 8,
P1Bm2011a-b and P1Bm2012a-b). Among the eight isolates of patient 1, no gradual increase
in antimicrobial resistance was observed, as the isolates collected in 2011 were already fully
resistant to virtually all compounds tested (Fig 2). We found an average mutation rate of 15
SNPs/year (S4 Fig) which was much higher than earlier reported values for B. multivorans
(2.2–2.4 SNPs/year), B. cenocepacia (1.7–2.1 SNPs/year) or B. dolosa (2.1 SNPs/year)
[39,40,42,43].
As expected from the evolution within the lungs of CF patients, we found a subset of genes
with mutations at multiple independent positions (Table 3) and 30 loci that had a mutation in
at least three patients (Table 4). As this latter set of genes underwent parallel adaptation in dif-
ferent patients, these genes may be involved in the adaptation of the ST-742 strain to the CF
lung environment. Importantly, we sought to correlate the loci we discovered to those found
in the B. multivorans literature. However, we found little commonalities despite almost all loci
being present on the ST-742 strain (Table 3, Table L in S1 Tables). Indeed, only three muta-
tions (i.e., ABC transporter permease, DNA-binding protein, and an acyltransferase) were
found in common with the fixed mutations found in the study by Silva et al. (2016). Another
three (hypothetical protein, LysR, and an amidophosphoribosyltransferase) mutations
matched to the list of 61 pathoadapted proteins reported by Caballero et al. (2018), and a single
Fig 8. Longitudinal evolution of isolates from patient 1. Single nucleotide polymorphisms (SNPs) are shown for each of the three chromosomes of B. multivorans.
When available, we additionally indicate the annotated function that is associated with the locus. The mutations that occur at multiple independent positions in the
same locus, which are indicative of selective pressure, are marked with number between parentheses (Table 4).
https://doi.org/10.1371/journal.ppat.1009418.g008
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Table 3. Loci with multiple independent mutations in patients 1 and 2. Genes with multiple mutations in the corresponding CDSs of the longitudinal isolates from
patient 1 (P1bm2009 –P1Bm2015) and patient 2 (P2Bm2011a, b), see Tables I and K in S1 Tables respectively. These adaptive mutations have not been reported in the B.
multivorans literature (Table L in S1 Tables).
Gene Product (locus) Patient Function Previously identified
PurB (0592) 1 Adenylosuccinate lyase no
Hypothetical (1166) 1 Fusaric acid resistance protein family no
Glycosyltransferase (2375) 1 LPS modification no
AlgP (2966) 1 Alginate production no
LysR (3936) 1 Regulation of transcription no
CheA (4025) 1 Chemotaxis no
FimV (4911) 1 Type IV motility, pilus assembly no
TetR (7680) 2 TetR family transcriptional regulator no
Amidase (20235) 2 Amidase protein no
https://doi.org/10.1371/journal.ppat.1009418.t003
Table 4. Loci undergoing parallel evolution in patients 1–4. List of 30 locus with mutations (SNPs) in at least three patients (see also Table I in S1 Tables). We separated
the isolates from 2011 and the isolate from 2018 in patient 2 as we regard them as two separate acquisition events.
Mutated locus present?
P1 P2_2011 P2_2018 P3 P4 Locus Gene Function
0129 MFS transporter
1045 plsX phosphate acyltransferase PlsX
1134 astD succinylglutamate-semialdehyde dehydrogenase
1149 nodulation protein
1201 DUF2242 domain-containing protein
1600 TetR family transcriptional regulator
1764 protease modulator HflC
1788 DNA polymerase III subunit gamma/tau
2211 DNA alkylation response protein
2519 ATPase
2580 amino acid permease
2840 potassium transporter
2966 alginate biosynthesis protein AlgP
3147 hypothetical protein
3210 rsmB 16S rRNA (cytosine(967)-C(5))-methyltransferase
3483 MFS transporter
3702 GNAT family N-acetyltransferase
3720 hemagglutinin
4338 molybdopterin-dependent oxidoreductase
4442 CBS domain-containing protein
4911 pilus assembly protein FimV
5135 hypothetical protein
5336 sensor histidine kinase
5391 helix-turn-helix transcriptional regulator
5441 type II toxin-antitoxin system RelE/ParE
5799 ABC transporter substrate-binding protein
6056 ctaD cytochrome c oxidase subunit I
6124 BON domain-containing protein
6144 DUF1269 domain-containing protein
6156 LysR family transcriptional regulator
https://doi.org/10.1371/journal.ppat.1009418.t004
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ABC transporter in common with the recent study by Hassan et al. (2020). Only one gene
(plsX, locus 1045) was previously reported by Silva et al. (2016) as part of adaptation within the
lungs (Table 4, Table L in S1 Tables), while all other genes that underwent parallel evolution
appear to be unique to this ST-742 lineage. This highlights the different strategies for adapta-
tion that can be used by different strains and the crucial need for large-scale investigations sim-
ilar to those conducted in B. dolosa, B. cenocepacia and P. aeruginosa [41,42,45]. This also
corroborates the work of Hassan et al. (2020) who discussed that different strains appeared to
have different routes of adaptation within the patient.
Using the short reads for SNP analysis, we observed that some regions of C1 and C2 had a
remarkably high SNP density extending over 250 kb and 70 kb, respectively (Figs 5 and 6,
Table J in S1 Tables). A previous study by Silva et al. (2016) hinted that potential hypermutator
phenotypes existed in B. multivorans due to mutations in the DNA mismatch-repair mecha-
nisms, specifically in MutL. However, we could not corroborate this hypothesis in our study.
Although disruptive mutations are reported in the MutL gene of isolates from Patient 2 and 4
(SNP analysis against P1Bm2009, Table I in S1 Tables), the gene is found correctly annotated de
novo in those isolates. Additionally, these regions were not identified as genomic islands, nor
were they flanked by mobile elements. Functional analysis of their coding content did not reveal
enrichments for specific COG categories when compared to the complete genome, which may
indicate that the recombination of this region is tolerated by ST-742 (Table M in S1 Tables). The
potential presence of these regions in other B. multivorans genomes (including both 97 public
and 59 non-public sequences from the National Reference Centre database) was analyzed using
BLASTn but no evidence was found that they originated from recombination between any of
those strains. This suggested that they may represent events of recombination with donor strains
for which no genome sequences are currently available. Additionally, as the start positions of the
high-density SNP regions differ in isolates from different patients and share significant numbers
of SNPs (Figs 5, 6 and 7 and S3, Table J in S1 Tables), these recombination events likely took
place prior to infection, not during co-infection of the patients airways, and contribute to the
microdiversity of the B. multivorans ST-742 population in its environmental reservoir [37,46].
Finally, from a technology perspective, we observed that while short read sequencing tech-
nologies such as Illumina were well suited to examine SNP diversity, long-read sequencing
technologies readily allowed us to observe differences in plasmid and prophage content. In
patient 2, we observed that prophages were mobile (Table 2), with an uncharacterized pro-
phage element that was present on C1 of P2Bm2011b but absent from P2Bm2011a and
P2Bm2018, and a second prophage, Burkholderia virus KS5 [47], that was present on C2 of
P2Bm2011a and P2Bm2018, yet absent from P2Bm2011b. This could be relevant as previous
studies in P. aeruginosa highlighted the importance of mobile prophage elements in driving
within-host adaptation of the infecting strains [48]. Interestingly, we also noted two variants
(deletions) in phosphoribosyltransferase and glycosyltransferase proteins that only appeared
in the large structural variation analysis (Table 5) and corresponded to loci reported by Cabal-
lero et al. [38]. These findings illustrate the limitations of Illumina-based SNP analysis in pro-




The strains used in this study were collected by the participating clinical laboratories in the
frame of routine diagnostic without additional testing and sent to the National Reference Center
for Burkholderia cepacia complex where they were stored in the frame of activities mentioned
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in the Royal Decree 9 February 2011 setting the conditions for funding for reference centers in
human microbiology and precised on the website of Sciensano: https://nrchm.wiv-isp.be/nl/
oproep2019/legaal/default.aspx. In the frame of the specific terms of reference for the NRC for
Burkholderia cepacia complex, a collection of representative strains was managed as outline in
https://nrchm.wiv-isp.be/nl/oproep2019/lastenboek/Rapporten/STR06-Burkholderia%
20cepacia_2019.pdf. Epidemiological data were collected retrospectively from patient charts
and anonymously stored in a database. As no additional sampling or information was asked
from patients, no formal approval from an ethical committee or informed consents are needed.
Bacterial isolates and patient data
The thirteen clinical isolates presented in this study (Table 1) were isolated from sputum sam-
ples of four patients diagnosed with cystic fibrosis (Fig 1) and were collected at the Belgian
National Reference Centre for Burkholderia cepacia complex (NRC Bcc). Isolates were identi-
fied as Burkholderia multivorans using MALDI-TOF mass spectrometry and recA gene
sequence analysis [19,49]. Isolates were further molecularly characterized by multi-locus
sequence typing (MLST) using the Bcc MLST scheme and the pubMLST database [19,21]. Iso-
lates were grown aerobically in lysogeny broth (LB) medium at 37˚C and cultures were pre-
served in 25% glycerol at -80˚C.
For patient 1, B. multivorans was first detected in a sputum sample at age nine (P1Bm2009,
January 2009). The initial treatment was intravenous (IV) ceftazidime, piperacillin-tazobactam
and ciprofloxacin for 14 days, followed by inhaled temocillin and oral ciprofloxacin for 3
months. Cultures were negative until August 2009, date after which they remained positive
until 2015, when the lung function declined drastically, and the patient received a double lung
transplant. In 2011, two isolates from the same sputum sample were examined as they dis-
played a different colony morphology (P1Bm2011a and P1Bm2011b), and similarly in 2012
with isolates P1Bm2012a and P1Bm2012b (Fig 1).
For patient 2, B. multivorans was first detected in a sputum sample, at age five (December 2009,
isolate not available for the NRC Bcc) and the infection is still ongoing at the time of the present
study. Treatment has included IV administration of ceftazidime-amikacin, tobramycin, piperacillin,
tazobactam, ciprofloxacin, and meropenem. Two isolates from the same sputum sample were sent
to the NRC in 2012 as they displayed distinct colony morphologies (P2Bm2012a and P2Bm2012b),
and an additional sample was received in 2018 (P2Bm2018) (Fig 1). Intermediate isolates (period
2012–2018) and later isolates (period 2019–2020) are not available for the NRC Bcc.
For patient 3, B. multivorans was first detected in a sputum sample at age nine (P3Bm2015,
November 2015). The infection was successfully eradicated with an IV course of ceftazidime
and tobramycin for 14 days, followed by 3 months of inhaled ceftazidime. No further samples
were collected since.
Table 5. List of large structural variations in the isolates of Patient 1. Using isolate P1Bm2009 as a reference, we mapped the long Nanopore reads of the subsequent
isolates from Patient 1 to reveal large structural variations that escape SNP analysis. All structural variations are found in C1 and are fixed after their appearance in agree-
ment with the SNP analysis (Fig 8). Isolates P1Bm2011a and P1Bm2012b, which originated from the same sputum sample as P1Bm2011b and P1Bm2012a, respectively,
appear to come from separate lineages.
Strains Chr Type Function
P1Bm2013-2015 1 Insertion Intergenic, IS3 in the rRNA cluster (5S, 16S, 23S)
P1Bm2011b-2015 1 Breakend Glycosyltransferase
P1Bm2011b-2015 1 Breakend Intergenic, next to IS256
P1Bm2011a-2015 1 Deletion Phosphoribosyltransferase
P1Bm2012b 1 Deletion Glycosyltransferase
P1Bm2015 1 Deletion SDR family NAD-p-dependent oxidoreductase
https://doi.org/10.1371/journal.ppat.1009418.t005
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For patient 4, B. multivorans was first detected in a sputum sample at age 25 (June 2017, not
available for the NRC Bcc) and an isolate was sent to the NRC in December 2019 (P4bm2019)
(Fig 1). The infection was treated for 14 days using intravenous meropenem, and no further
therapy was administered due to other health related complications.
Antibiotic sensitivity testing
We tested the in vitro susceptibility of all isolates against twenty different antibiotics (Table B
in S1 Tables) as described previously [50]. The MIC values were determined by microdilutions
in microtiter plates which were read on a Sensititre Vizion System device (ThermoScientific).
To determine the in vitro susceptibility, EUCAST pharmacokinetic/pharmacodynamics (PK/
PD) breakpoints were used, as no EUCAST species-specific breakpoints were available (tables
available at https://www.eucast.org/clinical_breakpoints/ PK PD breakpoints).
Genomic DNA isolation and hybrid sequencing
The isolates were inoculated in LB medium and grown overnight at 37˚C to stationary phase
(OD600 over 1.0). The genomic DNA was extracted using the QIAGEN DNeasy ultraclean
microbial kit. The quality and quantity of the extracted DNA was assessed using a Qubit 4.0
fluorometer, ThermoFisher Scientific Nanodrop spectrophotometer (OD280/260 and OD230/
260), and agarose gel electrophoresis (1% w/v).
The genomic DNA was sequenced combining both short-read and long-read technologies.
The first set of reads were obtained on an Illumina HiSeq4000 or NovaSeq6000 platform using
a paired-end 2�150 bp approach at the Oxford Genomics Centre. The second set of reads were
obtained on a MinION nanopore sequencer (Oxford Nanopore Technology) equipped with a
flowcell of type R9.4.1 and a library prepared either with the 1D ligation approach or the Rapid
library preparation kit (Table A in S1 Tables).
Hybrid genome assembly
Quality of the Illumina reads was assessed using FastQC v0.11.9 [51] and Trimmomatic v0.38
[52] was used for adapter clipping, quality trimming (LEADING:3 TRAILING:3 SLIDING-
WINDOW:4.15), and filtering on length (>50 bp). Quality of the Nanopore reads was assessed
using Nanoplot v1.28.2 [53], while Porechop v0.2.3 [54] was used for barcode clipping and
NanoFilt v2.6.0 [53] for filtering on quality (Q>8) and length (>500 bp).
The genomes of the isolates were assembled de novo using both the short-read SPAdes
assembler v3.14.0 [55], and the hybrid assembler Unicycler v0.4.7 [56] with default options. The
quality of the resulting assemblies was assessed using QUAST v5.0.2 [57] (S1 Fig) and the
assembly graphs were visualized with Bandage v0.8.1 [58]. Pairwise average nucleotide identities
between the ST-742 genomes were calculated using PYANI (v0.2.10) with the ANIb method.
Functional annotation
All genomes were functionally annotated via the NCBI Prokaryotic Genome Annotation Pipe-
line [59]. The proteome was also annotated with COG categories and KEGG pathways using
the eggNOG mapper [60]. This CDS-centric annotation was subsequently complemented by
annotating genetic systems and genomic islands with 1) the prophage detection system PHA-
STER [61], 2) CRISPRCasFinder software [62], 3) genomic IslandViewer v4 [63], 4) ABRicate
for the detection of acquired antimicrobial resistance genes [64], and 5) the biosynthetic gene
cluster annotation tool ANTISmash v5 [65].
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Population structure and MLST
To examine the position of the clinical isolates within the general population structure of B.
multivorans, all B. multivorans genomes were retrieved from the NCBI RefSeq database
(release 98) as GenBank files (Table D in S1 Tables), together with B. cenocepacia J2315 [66] as
an outgroup. Genomes with GC contents below 66% (one isolate), and more than 1,000 con-
tigs (seven isolates) were excluded. Remaining GenBank files were converted into gff3 files
using the perl script “bp_genbank2gff3” available in the BioPerl software library [67] and given
as input to roary v3.1 3 [68] to delineate the pangenome and perform a core gene multiple
sequence alignment. The core gene alignment was processed using FastTree v2.0 [69] to recon-
struct the population structure. The phylogenetic tree was visualized and annotated using Fig-
Tree v1.4.4 [70]. MLST analysis on all downloaded genomes was performed using mlst
(https://github.com/tseemann/mlst) and the Bcc pubMLST database [21].
SNP analysis
SNP calling was done using snippy v.4.4.5 [71] with the quality-controlled Illumina reads of
each isolate and the annotation of isolate P1Bm2009 or P2Bm2011a as reference. The SNP
density was calculated by tabulating the number of unique SNPs per 1000 nucleotides windows
along the genome (Figs 5, 6 and 7 and Table I in S1 Tables). The visualization of shared SNPs
(S3 Fig) was created with the software UpsetR [72] and the Venn web application (http://
bioinformatics.psb.ugent.be/webtools/Venn/). The core SNP alignment from snippy was used
to construct a focused phylogenetic tree of our ST-742 isolates and the strain FDAARGOS_719
using FastTree v2.0 [69] and visualized using FigTree v1.4.4 [70]. Comparisons with previously
published mutation data was conducted using BLASTp between the proteome of P1Bm2009
and the proteins reported in the studies listed in the Table L in S1 Tables.
Large genomic structural variations
Overall sequence identity as well as collinearity of the genomes was examined by creating dot plot
figures (S2 Fig) using Gepard v1.40 [73] with default options and word length adjusted to 100. The
large structural variations were called using a combination of the long-read mapper ngmlr v0.2.7
[74] and the structural variation caller sniffles v1.0.11 [74] with the quality-controlled Nanopore
reads and P1Bm2009 was as reference. The results were visually inspected using Ribbon v1.1 [75]
and all the VCF files were consolidated into a spreadsheet, with the following filters applied: 1) var-
iations related to the linearization of the replicons or smaller than 100 nt were removed, 2) impre-
cise variations were removed except when they matched a precise variations in another isolate, and
3) remaining variations in P1Bm2009 (three in total) were used to filter out false positives.
Supporting information
S1 Fig. Sequencing data, assembly metrics and assembly graphs. The assembly graphs for
the short-reads assemblies and hybrid assemblies are reported, enabling a quick visual inspec-
tion of the fragmentation of the assemblies as well as the presence of multiple replicons.
(PNG)
S2 Fig. Pairwise comparisons of the isolates chromosomes. Chromosomes 1, 2, and 3 were
compared in pairs using dot plots, highlighting the collinearity and overall sequence identity
of the genomes across all isolates. Note that some chromosomes were not fully closed and sub-
sequently rotated during the assembly resulting in visual artefacts including large inversions or
re-arrangements.
(PNG)
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S3 Fig. Shared and unique SNPs across the isolates from different patients. This visualiza-
tion supplements Figs 5, 6 and 7 by delineating the sharing of SNPs found in the different iso-
lates. For each chromosome, we provide two visualizations of the data using UpSetR and a
standard Venn diagram. We collapsed the 85 SNPs found in the isolates from P1Bm2009 to
P1Bm2015 and kept separate the P2Bm2011a,b and P2Bm2018 isolates from patient 2, as they
differed by 1,990 unique (not shared) SNPs.
(PNG)
S4 Fig. Cumulative SNPs Patient 1. The cumulative SNPs are plotted over the time period of
infection in patient 1. A linear model was used to estimate the rate of appearance of SNPs (15
SNPs/year).
(TIF)
S1 Tables. Table A: isolates description. The thirteen ST-742 isolates are listed with a sum-
mary description of their sequencing and the related genomics data available the NCBI Gen-
Bank database. Table B: antibiotic resistance profile. The table contains the MIC values for
all strains organized by type of antibiotics. The EUCAST or PK/PD interpretations are given
by color (RED = resistant, ORANGE = intermediate, GREEN = sensitive). Table C: location
of genomic islands and genetic clusters. Results from the three different software tools to pre-
dict the genomic locations of mobile elements and secondary metabolites clusters. Table D:
list of isolates from NCBI used for the population structure. The genome sequences of the
isolates were downloaded from the RefSeq database (release 98). Table E: features of plasmid
pP1Bm2009. List of annotated features of plasmid 1 in patient 1 annotated using hmmer and
eggNOG with a summary count of genes per COG categories. Table F: features of plasmid
pP2Bm2011a. List of annotated features of plasmid 1 in patient 2 annotated using hmmer and
eggNOG with a summary count of genes per COG categories and a comparison of COG cate-
gories between pP1Bm2009 and pP2Bm2011a. Table G: master list of large structural varia-
tions. List of all structural variations identified using the long reads (Nanopore data). Table H:
filtered list of large structural variations. The filtering steps are described in the Materials
and Methods section. Table I: master list SNPs. List of all SNPs identified when comparing
the 13 isolates against P1Bm2009. Table J: regions of high SNPs density. Detailed start and
stop positions of the regions displayed on the Figs 5, 6 and 7. Table K: SNPs isolates patient
2. List of SNPs identified when comparing the P2Bm2011b against P2Bm2011a. Table L: List
of loci under selection reported in previous studies. This list contains the loci that were
highlighted in previous longitudinal studies of B. multivorans infections of patients with cystic
fibrosis. For each study, we mention the locus number (as reported), the NCBI protein acces-
sion number, whether or not the locus was present in the ST-742 strains, and whether there
was a SNP found in the locus for the longitudinal isolates from patient 1. Table M: COG anno-
tation of the genes in high-density SNP regions. Here we list the proteins found in the
regions enriched in SNPs (Tables I and J in S1 Tables), functionally annotated with their COG
categories. The graphic at the top compares the specific presence of the COG categories in
those high-density SNP regions versus the complete genome.
(XLSX)
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